124 related articles for article (PubMed ID: 21074269)
1. Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia.
Qian J; Qian Z; Lin J; Yao DM; Chen Q; Li Y; Ji RB; Yang J; Xiao GF; Wang YL
Leuk Res; 2011 Jun; 35(6):783-6. PubMed ID: 21074269
[TBL] [Abstract][Full Text] [Related]
2. GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies.
Qian Z; Qian J; Lin J; Yao DM; Chen Q; Ji RB; Li Y; Xiao GF; Li JY
J Exp Clin Cancer Res; 2010 Aug; 29(1):111. PubMed ID: 20704716
[TBL] [Abstract][Full Text] [Related]
3. High expression of GTPase regulator associated with the focal adhesion kinase (GRAF) is a favorable prognostic factor in acute myeloid leukemia.
Aly RM; Ghazy HF
Blood Cells Mol Dis; 2014 Dec; 53(4):185-8. PubMed ID: 25088035
[TBL] [Abstract][Full Text] [Related]
4. [Quantification of GRAF gene expression in patients with acute myeloid leukemia using EvaGreen real time quantitative PCR].
Qian Z; Lin J; Qian J; Yao DM; Wang YL; Han LX; Zhu ZH; Xiao GF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):290-3. PubMed ID: 20533268
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
Yao DM; Qian J; Lin J; Wang YL; Chen Q; Qian Z; Li Y; Wang CZ; Yang J
Leuk Res; 2011 Jul; 35(7):957-60. PubMed ID: 21106240
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome.
Bojesen SE; Ammerpohl O; Weinhäusl A; Haas OA; Mettal H; Bohle RM; Borkhardt A; Fuchs U
Br J Cancer; 2006 Jan; 94(2):323-32. PubMed ID: 16404424
[TBL] [Abstract][Full Text] [Related]
7. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
9. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
[TBL] [Abstract][Full Text] [Related]
10. Promoter of TFPI-2 is hypermethylated in Chinese pediatric acute myeloid leukemia.
Jian P; Yan WS; Chao SL; Liang P; Zhen L; Ling QB; Hong LY; Ping LY; Jian W; Fang JM; Ling L; Dong WX; Ming ZX; Jian N
J Pediatr Hematol Oncol; 2012 Jan; 34(1):43-6. PubMed ID: 22052167
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of GTPase regulator associated with the focal adhesion kinase (GRAF) promoter is an adverse prognostic factor in myelodysplastic syndrome.
Qian J; Qian Z; Lin J; Yao DM; Zhu ZH; Chen Q; Xiao GF; Li JY
Eur J Haematol; 2010 Aug; 85(2):174-6. PubMed ID: 20374274
[No Abstract] [Full Text] [Related]
12. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation.
Tao YF; Xu LX; Lu J; Cao L; Li ZH; Hu SY; Wang NN; Du XJ; Sun LC; Zhao WL; Xiao PF; Fang F; Li YH; Li G; Zhao H; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
J Transl Med; 2014 Jun; 12():182. PubMed ID: 24962166
[TBL] [Abstract][Full Text] [Related]
14. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
[TBL] [Abstract][Full Text] [Related]
15. Methylation of CTNNA1 promoter: frequent but not an adverse prognostic factor in acute myeloid leukemia.
Chen XX; Lin J; Qian J; Qian W; Yang J; Ma JC; Deng ZQ; An C; Tang CY; Qian Z; Liu Q
Leuk Res; 2014 May; 38(5):613-8. PubMed ID: 24685333
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia.
Wong JJ; Lau KA; Pinello N; Rasko JE
Cancer Sci; 2014 Nov; 105(11):1457-63. PubMed ID: 25220401
[TBL] [Abstract][Full Text] [Related]
17. CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.
Li M; Gao L; Li Z; Sun J; Zhang H; Duan H; Ma Y; Wang C
Oncotarget; 2016 May; 7(21):31454-65. PubMed ID: 27129146
[TBL] [Abstract][Full Text] [Related]
18. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
[TBL] [Abstract][Full Text] [Related]
19. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
[TBL] [Abstract][Full Text] [Related]
20. Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
Zhang ZH; Zhang W; Zhou JD; Zhang TJ; Ma JC; Xu ZJ; Lian XY; Wu DH; Wen XM; Deng ZQ; Lin J; Qian J
Mol Carcinog; 2018 Jun; 57(6):735-744. PubMed ID: 29457658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
